F 0755
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Provide pharmaceutical services to meet the needs of each resident and employ or obtain the services of a
licensed pharmacist.
Based on medical record review, review of controlled drug administration records, staff interview, and
review of facility policy, the facility failed to ensure as-needed controlled medications were recorded on the
Medication Administration Record (MAR) when administered. This affected three residents (Residents #07,
#17, and #92) of three residents reviewed for controlled medications. The facility census was 91.
Findings include:
1. Review of the medical record for Resident #07 revealed an admission date of 10/05/2023. Diagnoses
included paraplegia, chronic pain, muscle weakness, and morbid obesity.
Review of Resident #07's plan of care, revised 10/18/23, revealed Resident #07 to be at risk for pain
related to diagnoses of chronic pain, low back pain, discitis and polyneuropathy. Interventions included to
provide non-pharmacological interventions, follow physician's orders for complaint of pain, and observe for
pain every shift. Additionally, the plan of care stated to provide medications per orders, monitor for signs
and symptoms of side effects and evaluate the effectiveness of the medication.
Review of Resident #07's physician's orders revealed an order dated 12/01/23 for oxycodone (an opioid
analgesic medication used for pain relief) five milligrams (mg) give two tablets by mouth every six hours as
needed (PRN) for pain.
Reconciliation of Resident #07's Controlled Drug Administration Record (CDAR) and Medication
Administration Record (MAR) for December 2023 revealed the following discrepancy related to oxycodone:
•
12/10/23 - four doses signed out on the CDAR, three doses recorded on the MAR
2. Review of the medical record for Resident #17 revealed an admission date of 10/02/23. Diagnoses
included fractures of the left tibia, right fibula, left humerus, and the lumbar vertebrae, an injury to the
external genitals, muscle weakness, and depression.
Review of Resident #17's plan of care, revised 10/16/23, revealed Resident #17 was at risk for pain related
to multiple fractures. Interventions included to provide non-pharmacological interventions, follow physician's
orders for complaint of pain, and observe for pain every shift. Additionally, the plan of care stated to provide
medications per orders, monitor for signs and symptoms of side
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 3
Event ID:
365623
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
365623
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
12/11/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Lake Pointe Health Care
3364 Kolbe Rd
Lorain, OH 44053
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0755
effects and evaluate the effectiveness of the medication.
Level of Harm - Minimal harm
or potential for actual harm
Review of Resident #17's physician's orders revealed an order dated 10/19/23 for oxycodone five mg, give
one tablet by mouth every six hours PRN for pain.
Residents Affected - Few
Reconciliation of Resident #17's MAR and CDAR for December 2023 revealed the following discrepancies
related to oxycodone:
•
12/01/23 - two doses signed out on the CDAR, zero doses recorded on the MAR
•
12/02/23 - two doses signed out on the CDAR, one dose recorded on the MAR
•
12/03/23 - two doses signed out on the CDAR, zero doses recorded on the MAR
•
12/04/23 - two doses signed out on the CDAR, one dose recorded on the MAR
•
12/06/23 - two doses signed out on the CDAR, one dose recorded on the MAR
•
12/07/23 - two doses signed out on the CDAR, one dose recorded on the MAR
•
12/08/23 - two doses signed out on the CDAR, one dose recorded on the MAR
•
12/09/23 - three doses signed out on the CDAR, one dose recorded on the MAR
•
12/11/23 - one dose signed out on the CDAR, zero doses recorded on the MAR
3. Review of the medical record for Resident #92 revealed an admission date of 12/07/23. Diagnoses
included metabolic encephalopathy, chronic respiratory failure, and alcohol abuse with withdrawal.
Review of Resident #92's physician's orders revealed an order dated 12/08/23 for lorazepam (a
benzodiazepine medication used to reduce anxiety) one mg, give one tablet by mouth every six hours PRN
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
365623
If continuation sheet
Page 2 of 3
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
365623
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
12/11/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Lake Pointe Health Care
3364 Kolbe Rd
Lorain, OH 44053
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0755
Level of Harm - Minimal harm
or potential for actual harm
for anxiety or alcohol withdrawal, with additional instructions to hold the medication if Resident #92 was
drowsy.
Reconciliation of Resident #92's CDAR and MAR for December 2023 revealed the following discrepancies
related to lorazepam:
Residents Affected - Few
•
12/08/23 - one dose signed out on the CDAR, zero doses recorded on the MAR
•
12/10/23 - one dose signed out on the CDAR, zero doses recorded on the MAR
Interview on 12/11/23 at 11:10 A.M. with the Director of Nursing (DON) and Regional Director of Clinical
Services (RDCS) #300 verified the CDAR and the MAR did not match for Residents #07, #17 and #92. The
DON and RDCS #300 verified nurses should document on the paper CDAR and the MAR, as both records
should match.
Review of the policy titled Medication Administration, undated, revealed the MAR to be the legal
documentation for medication administration. The policy identified that medications will be charted when
given and narcotics will be signed out when given. Documentation of medications will follow accepted
standards of nursing practice.
This deficiency represents non-compliance investigated under Complaint Number OH00148404.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
365623
If continuation sheet
Page 3 of 3